|
ARID4A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.59359999999787E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.31469999999656E-05 |
| Normal-vs-Stage2 |
1.817430E-03 |
| Normal-vs-Stage3 |
4.500800E-03 |
| Normal-vs-Stage4 |
2.169500E-04 |
| Stage1-vs-Stage2 |
8.084200E-01 |
| Stage1-vs-Stage3 |
7.240000E-01 |
| Stage1-vs-Stage4 |
3.213600E-01 |
| Stage2-vs-Stage3 |
6.138600E-01 |
| Stage2-vs-Stage4 |
4.090400E-01 |
| Stage3-vs-Stage4 |
1.946400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.23740000000672E-05 |
| Normal-vs-AfricanAmerican |
1.680580E-03 |
| Normal-vs-Asian |
7.256900E-03 |
| Caucasian-vs-AfricanAmerican |
7.739200E-01 |
| Caucasian-vs-Asian |
6.137000E-01 |
| AfricanAmerican-vs-Asian |
5.087600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.29290000000249E-05 |
| Normal-vs-Female |
2.623800E-02 |
| Male-vs-Female |
5.197600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.099600E-03 |
| Normal-vs-Extreme_Weight |
2.22420000000056E-05 |
| Normal-vs-Obese |
9.418800E-03 |
| Normal-vs-Extreme_Obese |
1.839390E-03 |
| Normal_Weight-vs-Extreme_Weight |
2.960600E-01 |
| Normal_Weight-vs-Obese |
3.814200E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.790400E-01 |
| Extreme_Weight-vs-Obese |
2.458200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.919600E-01 |
| Obese-vs-Extreme_Obese |
2.503000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.014170E-01 |
| Normal-vs-Age(41-60Yrs) |
9.724700E-03 |
| Normal-vs-Age(61-80Yrs) |
1.31920000001617E-06 |
| Normal-vs-Age(81-100Yrs) |
1.601530E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.242600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.396300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.944220E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.857330E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.836810E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.208400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.045700E-04 |
| Normal-VS-Type2 PRCC |
2.25099999995315E-06 |
| Normal-VS-KIRP CIMP |
1.711190E-01 |
| Normal-VS-Unclassified PRCC |
6.211800E-02 |
| Type1 PRCC-VS-Type2 PRCC |
8.328000E-02 |
| Type1 PRCC-VS-KIRP CIMP |
9.400000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.304400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.008200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.184240E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.902400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.93810000060202E-08 |
| Normal-vs-N1 |
4.750000E-02 |
| Normal-vs-N2 |
9.603700E-04 |
| N0-vs-N1 |
5.104000E-02 |
| N0-vs-N2 |
2.710800E-01 |
| N1-vs-N2 |
1.083590E-01 |
|
|
